Improved survival in rheumatoid arthritis: a general population-based cohort study

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2016-06-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/annrheumdis-2015-209058PMID 27338777PMCID PMC5182185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

  2016cited by this paper
• American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

  2015cited by this paper
• But how many people died? Health outcomes in perspective

  2015cited by this paper
• Profound reduction in hospital admissions and musculoskeletal surgical procedures for rheumatoid arthritis with concurrent changes in clinical practice (1995-2010).

  2015cited by this paper
• FRI0296 Is There A Difference in the Effectiveness in the Treatment of Rheumatoid Arthritis with Rituximab in Patients with Rheumatoid Factor Positive and Negative? A Systematic Review

  2014cited by this paper
• Mortality Trends in Patients With Early Rheumatoid Arthritis Over 20 Years: Results From the Norfolk Arthritis Register

  2014cited by this paper
• Selection bias in rheumatic disease research

  2014cited by this paper
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

  2013cited by this paper
• Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis.

  2013cited by this paper
• Additive Interaction in Survival Analysis: Use of the Additive Hazards Model

  2012cited by this paper
• Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates.

  2011cited by this paper
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

  2010cited by this paper
• Adaptation and validation of the Charlson Index for Read/OXMIS coded databases

  2010cited by this paper
• Study of a cohort of patients newly diagnosed with depression in general practice: prevalence, incidence, comorbidity, and treatment patterns.

  2010cited by this paper
• EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

  2009cited by this paper
• Validation of death and suicide recording on the THIN UK primary care database

  2009cited by this paper
• Do oral antimuscarinic drugs carry an increased risk of acute urinary retention?

  2009cited by this paper
• Rheumatoid arthritis in UK primary care: incidence and prior morbidity

  2009cited by this paper
• Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.

  2008cited by this paper
• How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database?

  2008cited by this paper
• Validation of THIN data for non-melanoma skin cancer.

  2008cited by this paper
• The widening mortality gap between rheumatoid arthritis patients and the general population.

  2007cited by this paper
• Nonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General Population

  2004cited by this paper
• Therapeutic strategies for rheumatoid arthritis.

  2004cited by this paper
• Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001.

  2004cited by this paper
• Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis.

  2002cited by this paper
• A multivariate technique for multiply imputing missing values using a sequence of regression models

  2001cited by this paper

• Insights Into Late‐Onset Rheumatoid Arthritis (LORA): Characteristics (Clinical and Imaging), Comorbidities, and Therapeutic Targets

  2026cites this paper
• ComputAgeBench: Epigenetic Aging Clocks Benchmark

  2025cites this paper
• JAK1-selective inhibitors versus pan-JAK inhibitors: comparative real-world study of drug retention in chronic inflammatory arthritis

  2025cites this paper
• Reduced mortality but elevated venous thromboembolism risk following knee and hip arthroplasty in patients with rheumatoid arthritis: A general population-based cohort study

  2025cites this paper
• Differences in Cause-Specific Mortality in Patients With Rheumatoid Arthritis by Sex and Seropositivity

  2025cites this paper
• Risk and temporal trends of heart failure subtypes in rheumatoid arthritis.

  2025cites this paper
• Projections of the Burden of Rheumatoid Arthritis in Mexico from 2020 to 2040.

  2025cites this paper
• Age-related disparities in biologic therapy initiation among rheumatoid arthritis patients: Insights from a large retrospective cohort study

  2025cites this paper
• 10 years in lupus - progress, but not enough.

  2025cites this paper
• Risk factors affecting the vital prognosis in patients with rheumatoid arthritis after primary cervical spine surgery: a retrospective study

  2025cites this paper
• Clinical variables and lung ultrasonography for the screening of interstitial lung disease in patients with rheumatoid arthritis

  2025cites this paper
• Real-World Safety and Efficacy of Targeted Therapies in Rheumatoid Arthritis: A 5-Year, 5130-Case Follow-Up from FIRST Registry

  2025cites this paper
• Association between frailty and oral function in rheumatoid arthritis patients: A multi-center, observational study

  2025cites this paper
• Mortality and Predictive Factors for Death Following the Diagnosis of Interstitial Lung Disease in Patients with Rheumatoid Arthritis: A Retrospective, Long-Term Follow-Up Study

  2025cites this paper
• Fibroblasts in rheumatoid arthritis: novel roles in joint inflammation and beyond

  2025cites this paper
• Cerebrovascular risk in rheumatoid arthritis patients: insights from carotid artery atherosclerosis in the Paracelsus 10,000 study

  2025cites this paper
• Is it time for treat to target in antiphospholipid syndrome?

  2024cites this paper
• Treatment of rheumatoid arthritis-associated interstitial lung disease: An appraisal of the 2023 ACR/CHEST guideline

  2024cites this paper
• Smoking-related bias of standardized mortality ratios in rheumatoid arthritis: A modeling study.

  2024cites this paper
• Clinical manifestations of rheumatoid arthritis, including comorbidities, complications, and long-term follow-up.

  2024cites this paper
• Causal relationship between rheumatoid arthritis and carpal tunnel syndrome: a bidirectional two-sample Mendelian randomization study

  2024cites this paper
• Targeting ferroptosis in autoimmune diseases: Mechanisms and therapeutic prospects.

  2024cites this paper
• Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism with JAK Inhibitors versus TNF Inhibitors in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis

  2024cites this paper
• Opportunities and challenges of lupus care in Latin America, the Middle East, and Asia-Pacific: A call to action.

  2024cites this paper
• Usefulness of Lung Ultrasound as a Method for Early Diagnosis of Interstitial Lung Disease in Patients with Rheumatoid Arthritis

  2024cites this paper
• Unclosing Premature Mortality Gap Among Patients With Gout in the US General Population, Independent of Serum Urate and Atherosclerotic Cardiovascular Risk Factors

  2024cites this paper
• Association of Hydroxychloroquine Use with a Dose-Dependent Decrease in Mortality Risk in Patients with Elderly-Onset Rheumatoid Arthritis

  2023cites this paper
• Risk of severe infections after the introduction of biologic DMARDs in people with newly diagnosed rheumatoid arthritis: a population-based interrupted time-series analysis.

  2023cites this paper
• Mortality estimates and excess mortality in rheumatoid arthritis

  2023cites this paper
• Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohort.

  2023cites this paper
• The Role of Leptin and Adiponectin in Rheumatoid Arthritis

  2023cites this paper
• Recent advances in unlinked total elbow arthroplasty in Japan

  2023cites this paper
• Elderly-Onset Rheumatoid Arthritis: Characteristics and Treatment Options

  2023cites this paper
• Time Trends of Cardiovascular Disease in the General Population and Inflammatory Arthritis.

  2023cites this paper
• Long-term outcomes in Rheumatoid Arthritis: Review of data from the ‘Basildon Inflammatory Arthritis Cohort’

  2022cites this paper
• Global epidemiology of rheumatoid arthritis

  2022cites this paper
• The Impact of Disease Severity Measures on Survival in U.S. Veterans with Rheumatoid Arthritis-Associated Interstitial Lung Disease.

  2022cites this paper
• Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohort

  2022cites this paper
• Neuronal CRMP2 phosphorylation inhibition by the flavonoid, naringenin, contributes to the reversal of spinal sensitization and arthritic pain improvement

  2022cites this paper
• Validation of grip strength as a measure of frailty in rheumatoid arthritis

  2022cites this paper
• Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis

  2022cites this paper
• A Narrowing Mortality Gap: Temporal Trends of Cause‐Specific Mortality in a National Matched Cohort Study in US Veterans With Rheumatoid Arthritis

  2022cites this paper
• Risk of COVID‐19 among unvaccinated and vaccinated patients with rheumatoid arthritis: a general population study

  2022cites this paper
• Prevalence, mortality, and treatment of patients with rheumatoid arthritis: a cohort study of the French Nation Health Data System, 2010-2019.

  2022cites this paper
• ‘Not at target’: prevalence and consequences of inadequate disease control in systemic lupus erythematosus—a multinational observational cohort study

  2022cites this paper
• A systematic review of quantitative bias analysis applied to epidemiological research.

  2021cites this paper
• The role of diet in hyperuricemia and gout

  2021cites this paper
• Type 2 diabetes mellitus, glycaemic control, associated therapies and risk of rheumatoid arthritis: a retrospective cohort study

  2021cites this paper
• Comprehensive risk analysis of postoperative complications in patients with rheumatoid arthritis for the 2020 update of the Japan college of rheumatology clinical practice guidelines for the management of rheumatoid arthritis.

  2021cites this paper
• Mortality rate in rheumatoid arthritis-related interstitial lung disease: the role of radiographic patterns

  2021cites this paper
• Dietary and Lifestyle-Centered Approach in Gout Care and Prevention

  2021cites this paper
• Non-causal Effect of Circulating Vitamin D Levels on the Risk of Rheumatoid Arthritis: A Two-sample Mendelian Randomization Study

  2021cites this paper
• Hospitalisation for systemic lupus erythematosus associates with an increased risk of mortality in Australian patients from 1980 to 2014: a longitudinal, population-level, data linkage, cohort study

  2021cites this paper
• All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015–2019

  2021cites this paper
• Extracorporeal Membrane Oxygenation in Immunocompromised Patients With Acute Respiratory Distress Syndrome—A Retrospective Cohort Study

  2021cites this paper
• Increased Risk of COVID‐19 in Patients With Rheumatoid Arthritis: A General Population‐Based Cohort Study

  2021cites this paper
• Update on gout management: what is old and what is new

  2021cites this paper
• Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care

  2021cites this paper
• Therapeutic Drug Monitoring for Immune-Mediated Inflammatory Diseases.

  2021cites this paper
• Persistent premature mortality gap in dermatomyositis and polymyositis: a United Kingdom general population-based cohort study.

  2020cites this paper
• Special Considerations in Geriatric Populations

  2020cites this paper
• Cardiovascular risk and mortality in rheumatoid arthritis compared with diabetes mellitus and the general population.

  2020cites this paper
• Trends in Hospitalization Rates, Major Causes of Hospitalization, and In‐Hospital Mortality in Rheumatoid Arthritis in the United States From 2000 to 2014

  2020cites this paper
• Ethnic Disparities in Atherosclerotic Cardiovascular Disease Incidence and Prevalence Among Rheumatoid Arthritis Patients in the United States: a Systematic Review

  2020cites this paper
• Rheumatoid Arthritis–Associated Interstitial Lung Disease: Current Update on Prevalence, Risk Factors, and Pharmacologic Treatment

  2020cites this paper
• Ten-year risk of cerebrovascular accidents in incident rheumatoid arthritis: a population-based study of trends over time.

  2020cites this paper
• Multiple biomarker approach for the diagnosis and therapy of rheumatoid arthritis

  2020cites this paper
• Chronic Heart Failure in Rheumatoid Arthritis Patients (Part III): Effects of Antirheumatic Drugs

  2020cites this paper
• Prognosis of pneumonia in patients with rheumatoid arthritis: the role of medication and disease activity prior to admission a population-based cohort study

  2020cites this paper
• Infections in Patients with Rheumatoid Arthritis in the Era of Targeted Synthetic Therapies

  2020cites this paper
• Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease

  2020cites this paper
• Mortality is increased in patients with rheumatoid arthritis or diabetes compared to the general population – the Nord-Trøndelag Health Study

  2020cites this paper
• Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis

  2020cites this paper
• Treat to Target

  2019cites this paper
• Cause‐Specific Mortality in Gout: Novel Findings of Elevated Risk of Non–Cardiovascular‐Related Deaths

  2019cites this paper
• Cost-Effectiveness of Early Treatment with Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients with Established Rheumatoid Arthritis

  2019cites this paper
• Efficacy of subcutaneous tocilizumab in patients with rheumatoid arthritis and systemic sclerosis overlap syndrome: a report of two cases and review of the literature

  2019cites this paper
• Ocular complications and mortality in peripheral ulcerative keratitis and necrotising scleritis: The role of systemic immunosuppression

  2019cites this paper
• Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians

  2019cites this paper
• Dynamics of body mass index and visceral adiposity index in patients with rheumatoid arthritis treated with tofacitinib

  2019cites this paper
• Treat-to-target Endpoint Definitions in Systemic Lupus Erythematosus: More Is Less?

  2019cites this paper
• Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study.

  2019cites this paper
• Rheumatoid Arthritis.

  2019cites this paper
• AB0665 OUTCOME OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SCLERODERMA, A 5 YEAR PROSPECTIVE COHORT STUDY

  2019cites this paper
• All‐Cause and Cause‐Specific Mortality Trends of End‐Stage Renal Disease Due to Lupus Nephritis From 1995 to 2014

  2019cites this paper
• AB0666 ALL-CAUSE AND CAUSE-SPECIFIC MORTALITY TREND IN PATIENTS WITH SYSTEMIC SCLEROSIS: A POPULATION-BASED STUDY

  2019cites this paper
• Potential benefits of biologics on stroke and mortality in patients with rheumatoid arthritis: A nationwide population‐based cohort study in Taiwan

  2019cites this paper
• Secular trends in risk of incident cardiovascular events in rheumatoid arthritis relative to the general population

  2019cites this paper
• Increased platelet reactivity as measured by plasma glycoprotein VI in gout

  2018cites this paper
• Dynamic of changes in coronary artery calcification in early rheumatoid arthritis patients over 18 months

  2018cites this paper
• Treat to target in gout

  2018cites this paper
• MACROPHAGE FUNCTIONAL DISORDERS IN RHEUMATOID ARTHRITIS AND ATHEROSCLEROSIS

  2018cites this paper
• Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR)

  2018cites this paper
• Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR)

  2018cites this paper
• Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999–2014)

  2018cites this paper
• Improving Mortality in End‐Stage Renal Disease Due to Granulomatosis With Polyangiitis (Wegener's) From 1995 to 2014: Data From the United States Renal Data System

  2018cites this paper
• Co‐morbidity and mortality among patients with interstitial lung diseases: A population‐based study

  2018cites this paper
• Strategien zur Prognoseverbesserung bei Patienten mit einer rheumatoideArthritis

  2018cites this paper
• Normal mortality of the COBRA early rheumatoid arthritis trial cohort after 23 years of follow-up

  2018cites this paper
• Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What’s the Difference?

  2018cites this paper